Skip to main content
Back to Seventure Partners

Seventure Partners's Biopharma Portfolio

Browse 6 Biopharma companies funded by Seventure Partners. See funding amounts, founder contacts, and investment details.

Biopharma Companies
6
Total Funding in Biopharma
$166.8M

Biopharma Portfolio Companies (6)

Export
BiopharmaBiotechnologyHealth CareLife Science

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Paris, France
June 2025
$19.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalMedical DeviceNeuroscience

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Oss, The Netherlands
December 2024
$89.7M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyOncology

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

Lyon, France
January 2026
$19.9M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Vertero Therapeutics is using cutting-edge research outside of the brain to treat neurodegenerative illnesses.

Woburn, United States
October 2025
$20.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyClinical Trials

A Paris-based biotechnology company .

Paris, France
July 2023
$2.4M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife Science

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

Louvain-la-neuve, Belgium
April 2018
$15.8M
Series A

Founder Contacts

19,000+ verified contacts

Explore Seventure Partners's Full Portfolio

View all companies funded by Seventure Partners across every industry and funding stage.

View Full Seventure Partners Portfolio